Published: 10-12-2024
Review
Insights into the paradoxical effect of smoking on vasculitis: a comprehensive review
Abstract 327 | PDF Downloads 249Page e2024053
Pulmonary rehabilitation in connective tissue disease-associated interstitial lung disease: A systematic review
Abstract 300 | PDF Downloads 208Page e2024061
Original Articles: Clinical Research
Comparing the utility of lung function parameters and fractional exhaled nitric oxide in predicting lung cancer
Abstract 183 | PDF Downloads 122Page e2024065
Diagnostic yield of a novel tracer 68Ga-citrate in sarcoidosis patients
Abstract 159 | PDF Downloads 101Page e2024064
Prolonged corticosteroid therapy and lung abnormalities in patients after severe COVID-19 pneumonia
Abstract 197 | PDF Downloads 109Page e2024052
Interstitial lung disease: retrospective study of the prognostic impact of acute exacerbations
Abstract 234 | PDF Downloads 169Page e2024051
Comparison of methotrexate and methylprednisolone as addition to antifibrotic therapy in progressive pulmonary fibrosis due to COVID-19
Abstract 267 | PDF Downloads 202Page e2024054
Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients
Abstract 360 | PDF Downloads 265Page e2024055
Lung cancer in patients with pulmonary fibrosis: characteristics features and prognosis
Abstract 353 | PDF Downloads 279Page e2024050
Sarcoidosis in north African people: about 35 cases
Abstract 199 | PDF Downloads 132Page e2024060
Quality of life, fatigue and markers in sarcoidosis: A section from Turkey
Abstract 158 | PDF Downloads 120Page e2024049
Autoantibodies in sarcoidosis: Innocent bystander or promising biomarker for organ involvement?
Abstract 237 | PDF Downloads 162Page e2024056
Images in Sarcoidosis
Eruptive cutaneous sarcoidosis – A rare phenomenon
Abstract 159 | PDF Downloads 107Page e2024058
Digital sarcoidosis with nail dystrophy
Abstract 158 | PDF Downloads 106Page e2024059
Mandibular and periodontal involvement in sarcoidosis
Abstract 108 | PDF Downloads 69Page e2024062
Letter to Editor
Sarcoidosis after Alemtuzumab therapy: Is Alemtuzumab posing a threat to its patients?
Abstract 169 | PDF Downloads 110Page e2024036
Comparative analysis of COVID-19-related mortality risk in chronic lower respiratory disease and interstitial lung disease
Abstract 122 | PDF Downloads 60Page e2024057
Online survey on existing sarcoidosis registries and biobanks: an ERN lung initiative.
Abstract 170 | PDF Downloads 105Page e2024063